Evidence of association with type 1 diabetes in the SLC11A1 gene region

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Yang, Jennie H M ^a   Downes, Kate ^a   Howson, Joanna M M ^a   Nutland, Sarah ^a   Stevens, Helen E ^a   Walker, Neil M ^a   Todd, John A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; RNA; CATION TRANSPORT PROTEIN; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; DISEASE MODEL; GENETICS; MOUSE; NONOBESE DIABETIC MOUSE;

ANIMALS; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MICE; MICE, INBRED NOD; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79955130312     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-59     Document Type: Article

References (73)

1. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41(6):703-707. 10.1038/ng.381, 2889014, 19430480.
2. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, Downes K, Barrett JC, Healy BC, Mychaleckyj JC, Warram JH, Todd JA. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008, 40(12):1399-1401. 10.1038/ng.249, 2635556, 18978792.
3. T1DBase. , https://www.t1dbase.org/page/Welcome/display
4. Maier L, Smyth D, Vella A, Payne F, Cooper J, Pask R, Lowe C, Hulme J, Smink L, Fraser H, Moule C, Hunter K, Chamberlain G, Walker N, Nutland S, Undlien D, Ronningen K, Guja C, Ionescu-Tirgoviste C, Savage D, Strachan D, Peterson L, Todd J, Wicker L, Twells R. Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes. BMC Genetics 2005, 6(1):9. 551616, 15720714.
5. Hill NJ, Lyons PA, Armitage N, Todd JA, Wicker LS, Peterson LB. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 2000, 49(10):1744-1747. 10.2337/diabetes.49.10.1744, 11016460.
6. Wicker LS, Chamberlain G, Hunter K, Rainbow D, Howlett S, Tiffen P, Clark J, Gonzalez-Munoz A, Cumiskey AM, Rosa RL, Howson JM, Smink LJ, Kingsnorth A, Lyons PA, Gregory S, Rogers J, Todd JA, Peterson LB. Fine Mapping, Gene Content, Comparative Sequencing, and Expression Analyses Support Ctla4 and Nramp1 as Candidates for Idd5.1 and Idd5.2 in the Nonobese Diabetic Mouse. J Immunol 2004, 173(1):164-173.
7. Kissler S, Stern P, Takahashi K, Hunter K, Peterson LB, Wicker LS. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat Genet 2006, 38(4):479-483. 10.1038/ng1766, 16550170.
8. Dai YD, Marrero IG, Gros P, Zaghouani H, Wicker LS, Sercarz EE. Slc11a1 Enhances the Autoimmune Diabetogenic T-cell Response by Altering Processing and Presentation of Pancreatic Islet Antigens. Diabetes 2008, db07-1608.
9. Cellier M, Govoni G, Vidal S, Kwan T, Groulx N, Liu J, Sanchez F, Skamene E, Schurr E, Gros P. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med 1994, 180(5):1741-1752. 10.1084/jem.180.5.1741, 2191750, 7964458.
10. BioGPS. , http://biogps.gnf.org
11. HaemAtlas. , http://dil.t1dbase.org/page/HaemAtlasView
12. Blackwell JM. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. Mol Med Today 1996, 2(5):205-211. 10.1016/1357-4310(96)88773-9, 8796889.
13. Blackwell JM, Searle S, Goswami T, Miller EN. Understanding the multiple functions of Nramp1. Microbes Infect 2000, 2(3):317-321. 10.1016/S1286-4579(00)00295-1, 10758409.
14. Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H, Li Y, Sarwar R, Langley SR, Bauerfeind A, Hummel O, Lee YA, Paskas S, Rintisch C, Saar K, Cooper J, Buchan R, Gray EE, Cyster JG, Braund P, Gracey J, Krishnan U, Moore JS, Nelson CP, Pollard H, Attwood T, Crisp-Hihn A, Foad N, Jolley J, Lloyd-Jones H, et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 2010, 467(7314):460-4. 10.1038/nature09386, 20827270.
15. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009, 155(2):173-181. 10.1111/j.1365-2249.2008.03860.x, 2675247, 19128359.
16. Richardson S, Willcox A, Bone A, Morgan N, Foulis A. Immunopathology of the human pancreas in type-I diabetes. Seminars in Immunopathology 2010, 1-13.
17. Fritsche G, Nairz M, Werner ER, Barton HC, Weiss G. Nramp1-functionality increases iNOS expression via repression of IL-10 formation. European Journal of Immunology 2008, 38(11):3060-3067. 10.1002/eji.200838449, 18991287.
18. Todd JA. Etiology of type 1 diabetes. Immunity 2010, 32(4):457-467. 10.1016/j.immuni.2010.04.001, 20412756.
19. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PCF, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH, Mathew CG, Schreiber S. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008, 40(11):1319-1323. 10.1038/ng.221, 18836448.
20. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, Ortmann W, Kosoy R, Ferreira RC, Nordmark G, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jonsen A, Bengtsson AA, Rantapaa-Dahlqvist S, Baechler EC, Brown EE, Alarcon GS, Edberg JC, Ramsey-Goldman R, McGwin G, Reveille JD, Vila LM, Kimberly RP, Manzi S, Petri MA, Lee A, Gregersen PK, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41(11):1228-1233. 10.1038/ng.468, 2925843, 19838195.
21. Greenwood CM, Fujiwara TM, Boothroyd LJ, Miller MA, Frappier D, Fanning EA, Schurr E, Morgan K. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000, 67(2):405-416. 10.1086/303012, 1287187, 10882571.
22. Li HT, Zhang TT, Zhou YQ, Huang QH, Huang J. SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis 2006, 10(1):3-12.
23. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998, 338(10):640-644. 10.1056/NEJM199803053381002, 9486992.
24. Gao PS, Fujishima S, Mao XQ, Remus N, Kanda M, Enomoto T, Dake Y, Bottini N, Tabuchi M, Hasegawa N, Yamaguchi K, Tiemessen C, Hopkin JM, Shirakawa T, Kishi F. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet 2000, 58(1):74-76.
25. Cervino AC, Lakiss S, Sow O, Hill AV. Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann Hum Genet 2000, 64(Pt 6):507-512.
26. Mohamed HS, Ibrahim ME, Miller EN, White JK, Cordell HJ, Howson JM, Peacock CS, Khalil EA, El Hassan AM, Blackwell JM. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur J Hum Genet 2004, 12(1):66-74. 10.1038/sj.ejhg.5201089, 14523377.
27. Taype CA, Castro JC, Accinelli RA, Herrera-Velit P, Shaw MA, Espinoza JR. Association between SLC11A1 polymorphisms and susceptibility to different clinical forms of tuberculosis in the Peruvian population. Infection, Genetics and Evolution 2006, 6(5):361-367. 10.1016/j.meegid.2006.01.002, 16461017.
28. Velez DR, Hulme WF, Myers JL, Stryjewski ME, Abbate E, Estevan R, Patillo SG, Gilbert JR, Hamilton CD, Scott WK. Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians. Int J Tuberc Lung Dis 2009, 13(9):1068-1076. 2902362, 19723394.
29. Castellucci L, Jamieson SE, Miller EN, Menezes E, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M, de Jesus AR, Carvalho EM, Blackwell JM. CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. BMC Med Genet 2010, 11:10. 2823618, 20089160.
30. Bassuny W, Ihara K, Matsuura N, Ahmed S, Kohno H, Kuromaru R, Miyako K, Hara T. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes. Immunogenetics 2002, 54(4):282-285. 10.1007/s00251-002-0459-3, 12136340.
31. Esposito L, Hill NJ, Pritchard LE, Cucca F, Muxworthy C, Merriman ME, Wilson A, Julier C, Delepine M, Tuomilehto J, Tuomilehto-Wolf E, Ionesco-Tirgoviste C, Nistico L, Buzzetti R, Pozzilli P, Ferrari M, Bosi E, Pociot F, Nerup J, Bain SC, Todd JA. Genetic analysis of chromosome 2 in type 1 diabetes: analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group. Diabetes 1998, 47(11):1797-1799. 10.2337/diabetes.47.11.1797, 9792551.
32. Nishino M, Ikegami H, Fujisawa T, Kawaguchi Y, Kawabata Y, Shintani M, Ono M, Ogihara T. Functional polymorphism in Z-DNA-forming motif of promoter of SLC11A1 gene and type 1 diabetes in Japanese subjects: Association study and meta-analysis. Metabolism 2005, 54(5):628-633. 10.1016/j.metabol.2004.12.006, 15877293.
33. Paccagnini D, Sieswerda L, Rosu V, Masala S, Pacifico A, Gazouli M, Ikonomopoulos J, Ahmed N, Zanetti S, Sechi LA. Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS ONE 2009, 4(9):e7109. 10.1371/journal.pone.0007109, 2740822, 19768110.
34. Shaw MA, Clayton D, Atkinson SE, Williams H, Miller N, Sibthorpe D, Blackwell JM. Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet 1996, 33(8):672-677. 10.1136/jmg.33.8.672, 1050702, 8863160.
35. Singal DP, Li J, Zhu Y, Zhang G. NRAMP1 gene polymorphisms in patients with rheumatoid arthritis. Tissue Antigens 2000, 55(1):44-47. 10.1034/j.1399-0039.2000.550107.x, 10703607.
36. Yang YS, Kim SJ, Kim JW, Koh EM. NRAMP1 gene polymorphisms in patients with rheumatoid arthritis in Koreans. J Korean Med Sci 2000, 15(1):83-87. 3054594, 10719815.
37. Ates T, Dalyan L, Müsellim B, Hatemi G, Türker H, Öngen G, Hamuryudan V, Topal-Sari{dotless}kaya A. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis. International Journal of Immunogenetics 2009, 36(1):15-19. 10.1111/j.1744-313X.2008.00814.x, 19055603.
38. Sanjeevi CB, Miller EN, Dabadghao P, Rumba I, Shtauvere A, Denisova A, Clayton D, Blackwell JM. Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum 2000, 43(6):1397-1404. 10.1002/1529-0131(200006)43:6<1397::AID-ANR25>3.0.CO;2-6, 10857800.
39. Runstadler JA, Saila H, Savolainen A, Leirisalo-Repo M, Aho K, Tuomilehto-Wolf E, Tuomilehto J, Seldin MF. Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: haplotype analysis in Finnish families. Arthritis Rheum 2005, 52(1):247-256. 10.1002/art.20772, 15641099.
40. Maliarik MJ, Chen KM, Sheffer RG, Rybicki BA, Major ML, Popovich J, Iannuzzi MC. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol 2000, 22(6):672-675.
41. Hofmeister A, Neibergs HL, Pokorny RM, Galandiuk S. The natural resistance-associated macrophage protein gene is associated with Crohn's disease. Surgery 1997, 122(2):173-178. discussion 178-179, 10.1016/S0039-6060(97)90006-4, 9288120.
42. Kojima Y, Kinouchi Y, Takahashi S, Negoro K, Hiwatashi N, Shimosegawa T. Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene. Tissue Antigens 2001, 58(6):379-384. 10.1034/j.1399-0039.2001.580606.x, 11929588.
43. Gazouli M, Atsaves V, Mantzaris G, Economou M, Nasioulas G, Evangelou K, Archimandritis AJ, Anagnou NP. Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease. Inflamm Bowel Dis 2008, 14(10):1323-1330. 10.1002/ibd.20488, 18454481.
44. Zaahl MG, Winter TA, Warnich L, Kotze MJ. The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population. Int J Colorectal Dis 2006, 21(5):402-408. 10.1007/s00384-005-0019-z, 16059695.
45. Kotlowski R, Bernstein CN, Silverberg MS, Krause DO. Population-based case-control study of alpha 1-antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2008, 14(8):1112-1117. 10.1002/ibd.20425, 18340647.
46. Ouchi K, Suzuki Y, Shirakawa T, Kishi F. Polymorphism of SLC11A1 (Formerly NRAMP1) Gene Confers Susceptibility to Kawasaki Disease. The Journal of Infectious Diseases 2003, 187(2):326-329. 10.1086/345878, 12552460.
47. Kotze MJ, de Villiers JNP, Rooney RN, Grobbelaar JJ, Mansvelt EPG, Bouwens CSH, Carr J, Stander I, du Plessis L. Analysis of the NRAMP1 Gene Implicated in Iron Transport: Association with Multiple Sclerosis and Age Effects. Blood Cells, Molecules, and Diseases 2001, 27(1):44-53. 10.1006/bcmd.2000.0349, 11358358.
48. Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Genetic susceptibility to Behcet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients. Rheumatol Int 2009, 29(7):787-791. 10.1007/s00296-008-0763-9, 18998137.
49. Zaahl MG, Warnich L, Victor TC, Kotze MJ. Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population. Cancer Genetics and Cytogenetics 2005, 159(1):48-52. 10.1016/j.cancergencyto.2004.09.017, 15860357.
50. Blackwell JM, Barton CH, White JK, Searle S, Baker AM, Williams H, Shaw MA. Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995, 1(2):194-205. 2229945, 8529098.
51. Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 1999, 36(4):295-299. 1734346, 10227396.
52. Zaahl MG, Robson KJH, Warnich L, Kotze MJ. Expression of the SLC11A1 (NRAMP1) 5'-(GT)n repeat: Opposite effect in the presence of -237C--T. Blood Cells, Molecules, and Diseases 2004, 33(1):45-50. 10.1016/j.bcmd.2004.04.003, 15223010.
53. The Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678. 10.1038/nature05911, 2719288, 17554300, The Wellcome Trust Case Control Consortium.
54. Cambridge BioResource. , http://www.cambridgebioresource.org.uk/
55. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009, 373(9680):2027-2033. 10.1016/S0140-6736(09)60568-7, 19481249.
56. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JHM, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B, Burren OS, Lam AAC, Ovington NR, Allen J, Adlem E, Leung H-T, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39(7):857-864. 10.1038/ng2068, 2492393, 17554260.
57. Wang WYS, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005, 6(2):109-118. 10.1038/nrg1522, 15716907.
58. 1000 Genomes Project. , http://www.1000genomes.org/
59. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, Maouche S, Germain M, Lackner K, Rossmann H, Eleftheriadis M, Sinning CR, Schnabel RB, Lubos E, Mennerich D, Rust W, Perret C, Proust C, Nicaud V, Loscalzo J, Hubner N, Tregouet D, Munzel T, Ziegler A, Tiret L, Blankenberg S, Cambien F. Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS ONE 2010, 5(5):e10693. 10.1371/journal.pone.0010693, 2872668, 20502693.
60. Kwan T, Benovoy D, Dias C, Gurd S, Provencher C, Beaulieu P, Hudson TJ, Sladek R, Majewski J. Genome-wide analysis of transcript isoform variation in humans. Nat Genet 2008, 40(2):225-231. 10.1038/ng.2007.57, 18193047.
61. U.K. GRID (Genetic Resource Investigating Diabetes) study. , http://www.childhood-diabetes.org.uk/grid.shtml
62. British 1958 Birth Cohort. , http://www.b58cgene.sgul.ac.uk/
63. UK Blood Service involvement in human genetics. , http://www.wellcome.ac.uk/News/Media-office/Press-releases/2005/WTX026809.htm
64. Type 1 Diabetes Genetics Consortium. , https://www.t1dgc.org/
65. JDRF/WT DIL sample collection. , http://www-gene.cimr.cam.ac.uk/todd/dna-refs.shtml
66. STATA statistical package. , http://www.stata.com
67. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, Guja C, Ionescu-Tirgoviste C, Widmer B, Dunger DB, Savage DA, Walker NM, Clayton DG, Todd JA. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006, 38(6):617-619. 10.1038/ng1800, 16699517.
68. Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, Smink LJ, Lam AC, Ovington NR, Stevens HE, Nutland S, Howson JM, Faham M, Moorhead M, Jones HB, Falkowski M, Hardenbol P, Willis TD, Todd JA. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 2005, 37(11):1243-1246. 10.1038/ng1653, 16228001.
69. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38(2):209-213. 10.1038/ng1706, 16415888.
70. Knapp M. A note on power approximations for the transmission/disequilibrium test. Am J Hum Genet 1999, 64(4):1177-1185. 10.1086/302334, 1377842, 10090903.
71. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002, 70(1):124-141. 10.1086/338007, 384883, 11719900.
72. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993, 52(3):506-516. 1682161, 8447318.
73. Primer3Plus software. , http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi